Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Idera Pharmaceuticals, Inc.

NASDAQ: IDRAHealthcare / Biotechnology / USA
2.6100.00Vol 78 9981Y Perf -83.82%
Mar 26th, 2019 11:52
BID2.60 ASK2.62
Open2.64 Previous Close2.61
Pre-Market- After-Trading-
 - -%  - -%
Target Price
14.40 
Analyst Rating
Strong Buy 1.00
Potencial %
447.53 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
★★★+ —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)72 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
2.42 
Earnings Date
8th May 2019

Today's Price Range

2.552.71

 

52wk Range

2.2517.12

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-11.22%
3 Months
-19.20%
6 Months
-71.26%
1 Year
-83.82%
3 Years
-83.61%
5 Years
-92.21%

Name / TickerPriceChg.Chg.%
IDRA2.610.00000.00
AAPL190.842.10001.11
GOOG1 189.60-3.4000-0.28
MSFT117.35-0.3100-0.26
XOM80.900.98001.23
WFC48.470.39000.81
JNJ138.862.25001.65
FB168.352.06001.24
GE9.990.11001.11
JPM98.990.06000.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
7.90
Current Ratio
8.10
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-5 442.70
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-9 043.80
EBITDA Margin
-8 978.50
Pre-tax Profit Margin
-18 451.90
Profit Margin
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
662
Revenue per Share
0.02
Revenue Growth 3 Years
0.45
Revenue Growth 5 Years
103.94

Earnings HistoryEstimateReportedSurprise %
Q04 2018-0.49-0.458.16
Q03 2018-0.56-0.4617.86
Q02 2018-0.80-0.5926.25
Q01 2018-0.72-0.80-11.11
Q04 2017-0.64-0.640.00
Q03 2017-0.96-0.8016.67
Q02 2017-0.88-1.12-27.27
Q01 2017-0.80-0.800.00
Earnings Per EndEstimateRevision %Trend
3/2019 QR-0.468.00Positive
6/2019 QR-0.479.62Positive
12/2019 FY-1.890.53Positive
12/2020 FY-1.831.61Positive
Next Report Date8th May 2019
Estimated EPS Next Report-0.46
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume78 998
Shares Outstanding (in ths.)27 620
Trades Count289
Dollar Volume192 976
Avg. Volume354 058
Avg. Weekly Volume358 747
Avg. Monthly Volume327 727
Avg. Quarterly Volume354 522

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

44%56%

Bearish Bullish

60%40%

Bearish Bullish

47%53%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
6 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News